1-6 of 6
Karenza Alexis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: The Phase 3, Randomized, Double-Blind, Placebo-Controlled QuANTUM-Wild Study of Quizartinib in Combination With Chemotherapy and as Single-Agent Maintenance in Newly Diagnosed, FLT3 -ITD-Negative Acute Myeloid Leukemia

Pau Montesinos, June-Won Cheong, Naval Daver, Amir T. Fathi, Mark J. Levis, Selina Luger, Toshihiro Miyamoto, Esther Natalie Oliva, Alexander E. Perl, Christian Récher, Richard F. Schlenk, Jianxiang Wang, Amer M. Zeidan, Li Liu, Yvonne Duong, Karima Imadalou, Karenza Alexis, Akash Nahar, Kristy Burns, Harry P. Erba
Journal: Blood
Blood (2024) 144 (Supplement 1): 1504.3.
https://doi.org/10.1182/blood-2024-205101
Published: 2024
Journal Articles

Innate Cell Engager (ICE®) AFM13 Combined with Preactivated and Expanded (P+E) Cord Blood (CB)-Derived Natural Killer (NK) Cells for Patients with Refractory CD30-Positive Lymphomas: Final Results

Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, Lori Griffin, Melissa Barnett, Christina Ganesh, Zephanie Borneo, Roland L. Bassett, Lucila Nassif Kerbauy, Rafet Basar, Mecit Kaplan, Daniel Esqueda, Jeremy Ramdial, Sairah Ahmed, Chitra Hosing, Samer A. Srour, Amin Alousi, Muzaffar H. Qazilbash, Raphael Eric Steiner, Karenza Alexis, Michael Emig, Andreas Harstrick, Elizabeth J. Shpall, Katayoun Rezvani
Journal: Blood
Blood (2023) 142 (Supplement 1): 774.
https://doi.org/10.1182/blood-2023-172980
Published: 2023
Journal Articles

AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgkin Lymphoma and CD30 + Peripheral T-Cell Lymphoma: A Phase 2 Study (LuminICE)

Alison Moskowitz, Andreas Harstrick, Michael Emig, Andre Overesch, Sheena Pinto, Paulien Ravenstijn, Thomas Schlüter, Jennifer Rubel, Hans Rebscher, Thorsten Graefe, John Lim, Heather Raymon, Karenza Alexis
Journal: Blood
Blood (2023) 142 (Supplement 1): 4855.
https://doi.org/10.1182/blood-2023-174250
Published: 2023
Journal Articles

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Yago Nieto, Pinaki P Banerjee, Indreshpal Kaur, Lori Griffin, Christina Ganesh, Lucila Kerbauy, Rafet Basar, Mecit Kaplan, Sanjida Islam, Daniel Esqueda, Roland Bassett, Melissa Timmons, Jeremy L. Ramdial, Samer A Srour, Neeraj Saini, Chitra Hosing, Sairah Ahmed, Swaminathan Padmanabhan Iyer, Karenza Alexis, Michael Emig, Andreas Harstrick, Elizabeth J Shpall, Katy Rezvani
Journal: Blood
Blood (2022) 140 (Supplement 1): 415–416.
https://doi.org/10.1182/blood-2022-156125
Published: 2022
Journal Articles

What Is the Patient Risk from a Bone Marrow Biopsy By Hematologists-in-Training? A Prospective, Clinical Study

Shirin Attarian, MD, Louis Juden Reed, MD, Shashi Singh, MD, Gopichand Pendurti, MBBS, Alexander Shestopalov, MD, Aditi P. Singh, MD, Anjali Budhathoki, MD, Simon Abi Aad, MD, Urvi A Shah, MD, Salem Kim, MD, Kimo Bachiashvili, MD, Tarek Elrafei, DO, Karenza Alexis, MD, Marianna Strakhan, MD, Weijuan Li, MS,MD, Conway Yee, MD, Ellen W. Friedman, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5638.
https://doi.org/10.1182/blood.V130.Suppl_1.5638.5638
Published: 2017
Journal Articles

Economic, Transfusion, and Efficacy Outcomes with the Addition of IV Iron Sucrose to Oral Iron Therapy in Pregnancy Associated Iron Deficiency Anemia

Nilupa Gaspe Mudiyanselage, MD, Tarek Elrafei, DO, Beth Lewis, MD, Mary King, MD, Marianna Strakhan, MD, Karenza Alexis, MD, Richard Gralla, MD
Journal: Blood
Blood (2016) 128 (22): 4737.
https://doi.org/10.1182/blood.V128.22.4737.4737
Published: 2016